Global Interventional Oncology Market Size & Outlook
Global interventional oncology market, 2021-2033 (US$M)
Related Markets
Global interventional oncology market highlights
- The global interventional oncology market generated a revenue of USD 2,905.2 million in 2025 and is expected to reach USD 5,610.2 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 8.6% by 2033.
- In terms of segment, ablation therapies accounted for a revenue of USD 1,234.7 million in 2025.
- Ablation Therapies is the most lucrative technique segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, Mexico is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 2,905.2 million |
| Market revenue in 2033 | USD 5,610.2 million |
| Growth rate | 8.6% (CAGR from 2026 to 2033) |
| Largest segment | Ablation therapies |
| Fastest growing segment | Ablation Therapies |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Ablation Therapies, Embolization Therapies, Biopsy Techniques, Targeted Therapy Delivery Systems, Image-Guided Procedures |
Other key industry trends
- In terms of revenue, the North America accounted for 41.8% of the global interventional oncology market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, Mexico is the fastest growing regional market and is projected to reach USD 70.8 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Interventional Oncology Market Scope
Interventional Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| C. R. Bard, Inc. | View profile | - | - | - |
| AngioDynamics Inc | View profile | 815 | 14 Plaza Drive, Latham, NY, United States, 12110 | https://www.angiodynamics.com |
| Cook Medical | View profile | 10001+ | Bloomington, Indiana, United States, North America | http://www.cookmedical.com |
| B. Braun Medical | View profile | 10001+ | Bethlehem, Pennsylvania, United States, North America | http://www.bbraunusa.com |
| Terumo Corp | View profile | 30207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | https://www.terumo.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Global interventional oncology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional oncology market will help companies and investors design strategic landscapes.
Ablation therapies was the largest segment with a revenue share of 42.5% in 2025. Horizon Databook has segmented the Global interventional oncology market based on ablation therapies, embolization therapies, biopsy techniques, targeted therapy delivery systems, image-guided procedures covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Interventional Oncology Technique Outlook (Revenue, USD Million, 2021-2033)
- Ablation Therapies
- Radiofrequency Ablation (RFA)
- Microwave Ablation (MWA)
- Cryoablation
- Laser Ablation
- Irreversible Electroporation (IRE)
- Embolization Therapies
- Transarterial Chemoembolization (TACE)
- Transarterial Radioembolization (TARE)
- Biopsy Techniques
- Core Needle Biopsy
- Fine Needle Aspiration (FNA)
- Targeted Therapy Delivery Systems
- Drug-Eluting Beads
- Radioembolization
- Drug-Eluting Stents
- Injectable Hydrogels and Nanoparticles
- Other Targeted Therapy Systems
- Image-Guided Procedures
- Ultrasound Guidance
- CT Scan Guidance
- MRI Guidance
- Fluoroscopy Guidance
- Ablation Therapies
- Global Interventional Oncology Procedures Outlook (Revenue, USD Million, 2021-2033)
- Tumor Ablation
- Tumor Biopsy
- Vascular Interventions
- Palliative Care
- Global Interventional Oncology Application Outlook (Revenue, USD Million, 2021-2033)
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Prostate Cancer
- Breast Cancer
- Other Cancer
- Global Interventional Oncology End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Specialty Clinics
- Others End Use
Reasons to subscribe to Global interventional oncology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global interventional oncology market databook
-
Our clientele includes a mix of interventional oncology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global interventional oncology market , including forecasts for subscribers. This global databook contains high-level insights into Global interventional oncology market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global interventional oncology market size, by regions, 2021-2033 (US$M)
Top 10 countries: Interventional oncology market size, 2025 (US$M)
Global interventional oncology market share, by technique, 2025 & 2033 (%, US$M)
Interventional oncology market: Opportunity assessment by country
Global interventional oncology market, by region, 2025 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
